An Open-Label Ascending Single-Dose, and Randomized, Double-blind, Placebo-controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CST-2032 in Healthy Volunteers and Subjects with Mild Cognitive Impairment or Parkinson's Disease
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Kerris, Jarrod (Project Manager)
Project: Research